Enable® Aortic Sutureless Bioprosthesis Evaluation

CompletedOBSERVATIONAL
Enrollment

225

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Aortic Valve StenosisAortic Valve Insufficiency
Interventions
PROCEDURE

Aortic Valve Replacement surgery

Aortic Valve Replacement surgery of the native aortic valve with the Enable® aortic bioprosthesis.

Trial Locations (17)

3010

Inselspital, Bern

20157

Ospedale Luigi Sacco, Milan

26133

Klinikum Oldenburg GmbH, Oldenburg

28007

Hospital General Universitario Gregorio Marañón, Madrid

30625

Medizinische Hochschule Hannover (MHH), Hanover

38001

Hospiten Rambla, Santa Cruz de Tenerife

40225

Universitätsklinikum Düsseldorf (UKD), Düsseldorf

48149

Universitätsklinikum Münster (UKM), Münster

59037

Centre Hospitalier Régional Universitaire de Lille (CHRU), Lille

80636

Deutssches Herzzentrum Muenchen, Munich

83013

Casa Di Cura Privata 'Montevergine' S.p.A., Mercogliano

89081

Universitätsklinikum Ulm, Ulm

Unknown

Centre Hospitalier Universitaire de Saint-Etienne Hôpital Nord, Saint-Etienne

00135

Azienda Complesso Ospedaliero S.Filippo Neri, Rome

8934AD

Medisch Centrum Leeuwarden, Leeuwarden

2300 RC

Leids Universitair Medisch Centrum, Leiden

TS4 3BW

The James Cook University Hospital, Middlesbrough

All Listed Sponsors
lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT01720342 - Enable® Aortic Sutureless Bioprosthesis Evaluation | Biotech Hunter | Biotech Hunter